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Background: Abdominal obesity (AO) is a medical condition in which excess body fat accumulates in the
abdomen. It may cause adverse effects on health and result in reduced life expectancy or increased health
problems. While various genetic approaches have explained the risks of AO in Western society, the Sasang
constitution (SC) has been identified as a risk factor in Korean medicine. Different SC types are associated with
different fat distribution, body shapes and susceptibility to diseases. We evaluated whether the SC type could be a
risk for AO in a cross-sectional study among Koreans.
Methods: In total, 2,528 subjects aged over 30 years were recruited from 23 medical clinics. We collected waist
circumference (WC), weight, height, and some clinical information for AO from the subjects. A Chi-square test and a
one-way ANOVA were performed according to SC type (p < .05), while multiple logistic regression was used to
produce odds ratios (ORs).
Results: The rates of AO in Tae-eumin (TE), Soeumin (SE), and Soyangin (SY) types were 63.7%, 14.7%, and 32.8% in
males and 84.8%, 41.7%, and 52.8% in females, respectively. The TE type was associated with increased AO
prevalence compared with the SE and SY types in males (OR 1.79; 95% CI 1.02–3.15, p = 0.044 and OR 1.74; 95% CI
1.18–2.58, p = 0.006, respectively) and females (OR 1.51; 95% CI 1.03–2.23, p = 0.037 and OR 1.88; 95% CI 1.32–2.68,
p < 0.001, respectively) after adjusting for age, BMI, hypertension, diabetes mellitus, hypertriglyceridemia, and low
HDL cholesterol.
Conclusions: This study suggested that SC, particularly the TE type, might be significantly and independently
associated with AO and could be considered a risk factor in predicting AO.
Keywords: Abdominal obesity, Sasang constitutional medicine, Prevalence, Waist circumference, Risk factorBackground
Obesity is a medical condition in which excess body
fat has accumulated to the extent that it may have an
adverse effect on health, leading to reduced life expect-
ancy and/or increased health problems [1]. Obesity, es-
pecially abdominal obesity (AO), is a substantial risk
factor for hypertension, metabolic disease, cardiovascu-
lar disease, gallbladder disease, osteoarthritis, and sleep
apnea [2].
Furthermore, the waist circumference (WC) plays
pivotal roles in those diseases because of its central
fat distribution [3-7]. Therefore, the World Health
Organization (WHO) has classified obese guide* Correspondence: bfree@kiom.re.kr
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reproduction in any medium, provided the oraccording to not only body mass index (BMI) but also
WC [8] and the National Cholesterol Education Program
Adult Treatment Panel III also has defined AO as one of
important factors for metabolic syndrome [9]. Eventu-
ally, the WHO has identified that human beings should
overcome AO in the 21st century and observed that the
wait for a cure may take a long time [10]. The funda-
mental cause of AO is presumed to be a combination of
environmental factors (inappropriate eating and physical
inactivity) and the organism’s genes, such as the 5-HT2A
gene and glucocorticoid receptor (GR) gene in Western
society [11-15].
Sasang constitutional medicine (SCM) is a tailored
Korean traditional medicine that classifies human
beings into four constitutions: Taeyangin (TY), Soyangin
(SY), Tae-eumin, (TE), and Soeumin (SE) [16]. Eachd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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face, voice, and psychological and physiological aspects
[17,18], and those characteristics are different from one
constitution to another [19]. Therefore, each constitution
has a different susceptibility to pathology and several
chronic diseases. Hypertension and diabetes mellitus
(DM) were revealed to be associated with a specific Sasang
constitution (SC) [19-23].
According to SCM theory, lung hypo-function and
liver hyper-function are related to a large WC, and the
TE type is associated with hyperactive liver function and
a developed waist area [16,17]. We hypothesize that SC
could be a risk for AO. Several family studies have been
conducted to investigate the genetic evidence for SC,
and they found that SC could be not only inherent but
also a risk factor for obesity [24,25]. However, there has
been no clinical study to show that SC could a risk fac-
tor for AO.
In this study, we present indirect evidence of whether
SC could be a risk factor for AO among Koreans.
Methods
This was a cross-sectional study conducted from Nov.
2007 to Jul. 2011 in 23 Korean medical clinics (KMCs).1)BMI unmeasured, 2)TY Group, KMD, Korea Medical Doc
TE, Tae-eumin; SE, Soeumin; SY, Soyangin; AO, Abdomin
Figure 1 The flow chart of the study.Study subjects and size
The study size was assumed from a Bernoulli distribu-
tion. We calculated a sample size of at least 600 subjects
of each constitution on the basis of a 95% confidence
interval and a 4% margin of error. The eligible subjects
were recruited from KMCs among individuals over 30
years old whose constitution had been confirmed by ex-
perts in SC. Individuals who could not understand and
follow the researcher’s indication or keep their mea-
surement posture because of severe physical/mental ill-
ness were excluded. The detailed researcher’s indication
and the subjects’ measurement posture were described
in Jang’s study [26]. The subjects with body deformation
such as lump or congenital malformation in the measure-
ment location, or pregnant women were also excluded. A
total of 2,598 subjects (931 males and 1,667 females) were
recruited from 23 KMCs. Three of them were excluded
because of missing data. A total of 67 TY types were also
excluded because of their low proportion in the Korean
population. In total, 2,528 subjects (909 males and 1,619
females) were included in the final analysis. A flowchart of
the study design is shown in Figure 1.
This study was approved by the Korea Institute of
Oriental Medicine (KIOM) Institutional Review Boardtor; SC, Sasang Constitution; 
al obesity; NO, Non-obese. 
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tion in this study was obtained from each of the subjects.Sasang constitutional diagnosis
An SCM expert at each hospital diagnosed individual
SC types. For accurate diagnoses, we strictly adhered
to defined qualifications of the experts and subject
criteria. The SCM experts had more than 5 years of
experience in clinical practice. The administration of
constitution-specific pharmaceuticals was used as an
additional method to confirm the subject SC. A more
detailed procedure of diagnosing SC was described in
Song’s study [27].Data collection
We collected WC measurements to determine the AO
prevalence according to SC. We also collected data on
age, sex, body mass index (BMI), and blood pressure
and blood samples to control for the influence of con-
founding factors, which are important risk factors for
AO [28,29]. WC was measured around the level of the
umbilical scar of the subjects, who took their upper
clothing off and stood in an erect posture with their
arms folded in front of their chest [26]. BMI was indir-




Number (%) 407 (44.8)
Age (years) 52.5 ± 12.1b
BMI (kg/m2) 25.8 ± 2.8b,c
Systolic blood pressure (mmHg) 127.2 ± 14.5b,c
Diastolic blood pressure (mmHg) 81.7 ± 10.5b
Fasting blood glucose (mg/dl) 105.6 ± 31.2
TG (mg/dl) 170.0 ± 106.4b
HDL cholesterol (mg/dl) 39.1 ± 9.6b,c
WC (cm) 92.4 ± 7.4
Female
Number (%) 625 (38.6)
Age (years) 53.6 ± 12.7b,c
BMI (kg/m2) 25.5 ± 3.0b,c
Systolic blood pressure (mmHg) 122.6 ± 17.2b,c
Diastolic blood pressure (mmHg) 78.3 ± 11.7b,c
Fasting blood glucose (mg/dl) 101.7 ± 315b
TG (mg/dl) 137.2 ± 89.4b,c
HDL cholesterol (mg/dl) 45.5 ± 12.3b,c
WC (cm) 88.9 ± 8.8
Data shown are the mean ± SD, unless otherwise indicated. aSoeumin and Soyangin
and Tae-eumin differ significantly. TE, Tae-eumin; SE, Soeumin; SY, Soyangin; BMI, Bblood pressure was measured from each subject’s left
upper arm after enough rest. To reduce measurement
bias among the KMCs, all instructors were educated by
KIOM at least once per year, and KIOM monitored the
progress of the data collection. All instructors followed a
standard operation procedure (SOP) that was developed
for the “Korea Constitution Multicenter Study” [26,30].
Blood samples were collected after more than 12 hours
of fasting, and the fasting blood glucose, triglyceride (TG)
and HDL cholesterol levels were tested by an authorized
institution.Diagnostic criteria
Hypertension was diagnosed by following the guidelines
of the 7th Report of the JNC as ≥ 90 mmHg for diastolic
pressure, ≥140 mmHg for systolic pressure or taking
medicine for the treatment of high blood pressure [31].
DM was diagnosed with the ADA criteria as ≥126 mg/dl
of fasting plasma glucose or taking medicine for the treat-
ment of DM [32]. Hypertriglyceridemia was diagnosed as
TG ≥150 mg/dl, and low HDL cholesterol was diagnosed
as HDL cholesterol <40 mg/dl in males and <50 mg/dl
in females. To diagnose AO, we followed the WHO Re-
port of Asia-Pacific guideline of WC ≥ 90 cm for males
and ≥ 80 cm for females [33].nd constitution
Constitution type P value
SE SY
191 (21) 311 (34.2)
48.5 ± 12.2a,b 52.8 ± 12.4a <0.001
21.9 ± 2.5a,b 23.7 ± 2.6a,c <0.001
120.4 ± 14.6b 122.8 ± 14.5c <0.001
77.4 ± 11.3a,b 79.7 ± 10.1c <0.001
100.8 ± 33.7 105.8 ± 33.6 0.17
126.0 ± 67.1a,b 158.3 ± 106.0c <0.001
43.2 ± 9.9b 41.8 ± 11.1c <0.001
82.2 ± 7.1 86.5 ± 7.9 <0.001
441 (27.2) 553 (34.2)
49.3 ± 12.9b 50.19 ± 12.1c <0.001
21.5 ± 2.5a,b 22.8 ± 2.6a,c <0.001
116.2 ± 16.0b 117.3 ± 14.6c <0.001
74.2 ± 11.3b 75.2 ± 10.5c <0.001
92.9 ± 15.6a,b 98.0 ± 32.1c <0.001
100.8 ± 57.7a,b 115.9 ± 68.2a,c <0.001
51.0 ± 12.6a,b 48.5 ± 12.4a,c <0.001
78.6 ± 8.1 81.2 ± 8.2 <0.001
differ significantly, bSoeumin and Tae-eumin differ significantly, cSoyangin
ody mass index; TG, Triglycerides; WC, Waist circumference.
Table 2 Prevalence of abdominal obesity stratified by
gender and constitution
Variables Constitution type Total P value
TE SE SY
Male
AO 259 (63.7) 28 (14.7) 102 (32.8) 389 (42.8)
NO 148 (36.3) 163 (85.3) 209 (67.2) 520 (57.2) <0.001
Total 407 (100) 191 (100) 311 (100) 909 (100)
Female
AO 530 (84.8) 184 (41.7) 292 (52.8) 1006 (62.1)
NO 95 (15.2) 257 (58.3) 261 (47.2) 613 (37.9) <0.001
Total 625 (100) 441 (100) 553 (100) 1619 (100)
Data are shown as the n (%). TE, Tae-eumin; SE, Soeumin; SY, Soyangin;
AO, Abdominal obesity; NO, Non-obese.
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Considering the influence of sexual differences, all ana-
lyses were separately conducted in males and females. A
one-way ANOVA was used to compare continuous vari-
ables (Scheffé’s post-hoc analysis). A Chi-square test was
performed to compare the prevalence of AO according
to SC. Multiple logistic regression was used to calculate
odds ratios (ORs) for AO. To evaluate whether the SC
could be a risk factor for AO, covariant variables, inclu-
ding age, BMI, hypertension, DM, hypertriglyceridemia,
and low HDL cholesterol, were considered. We conduc-
ted all of the analyses using SPSS 17.0 software (SPSS
Inc., Chicago, IL). The statistical levels of significance
were considered to be p values <0.05.Results
General characteristics
The distribution of SC into TE, SE, and SY types was
44.8%, 21%, and 34.2% in males and 38.6%, 27.2%, and
34.2% in females, respectively. The subjects’ general cha-
racteristics, including age, body mass index, systolic blood
pressure, diastolic blood pressure, fasting blood glucose,
TG, HDL cholesterol, and WC, are shown in Table 1 ac-
cording to gender and constitution.Table 3 Adjusted odds ratios and 95% CI for abdominal obes
Variables Model 1 Mod
OR (95% CI) P value OR
Male
SE Type:TE Type 1:10.19 (6.5–15.96) <0.001 1:1.7
SY Type:TE Type 1:3.59 (2.63–4.9) <0.001 1:1.7
Female
SE Type:TE Type 1:7.79 (5.84–10.4) <0.001 1:1.6
SY Type:TE Type 1:4.99 (3.79–6.56) <0.001 1:1.9
Results from logistic regression analysis, Model 1- crude. Model 2- adjusted for age
hypertriglyceridemia, and low HDL cholesterol. TE, Tae-eumin; SE, Soeumin; SY, SoyThe rate of AO according to SC
The rate of AO was 42.8% in males and 62.1% in fe-
males. The prevalence of AO differed significantly ac-
cording to constitution. The male AO rate according to
constitution was 63.7% in the TE type, 14.7% in the SE
type and 32.8% in the SY type, and the female AO rate
according to constitution was 84.8% in the TE type,
41.7% in the SE type and 52.8% in the SY type. The de-
tails are shown in Table 2.ORs for AO before and after adjustment
Table 3 shows a sequentially developed multiple logistic
regression model of AO. Model 1 was crude, without ad-
justment, model 2 was adjusted for age and BMI, and
model 3 was adjusted for age, BMI, hypertension, DM,
hypertriglyceridemia, and low HDL cholesterol. Because
the TE type was assumed to be a more dangerous risk
factor than other types, the results were described as SE
type versus TE type and SY type versus TE type.
The result revealed that the TE type was associated
with increased AO prevalence compared with SE and SY
types in males (model 1, OR 10.19; 95% CI 6.5–15.96,
p < 0.001 and OR 3.59; 95% CI 2.63–4.9, p < 0.001,
respectively). The TE type remained significantly asso-
ciated with increased AO prevalence after adjusting for
age and BMI (model 2, OR 1.77; 95% CI 1.01-3.16, p =
0.045 and OR 1.72; 95% CI 1.17-2.53, p = 0.006, respec-
tively) and age, BMI, hypertension, DM, hypertriglyce-
ridemia, and low HDL cholesterol (model 3, OR 1.79;
95% CI 1.02-3.15, p = 0.044 and OR 1.74; 95% CI 1.18–
2.58, p = 0.006, respectively).
We also found a similar trend in females. The TE type
was associated with increased AO prevalence compared
with SE and SY types (model 1, OR 7.79; 95% CI 5.84–
10.4, p < 0.001 and OR 4.99; 95% CI 3.79–6.56, p < 0.001,
respectively), and the TE type remained significantly as-
sociated with increased AO prevalence after adjusting
for age and BMI (model 2, OR 1.65; 95% CI 1.13–2.41,
p = 0.01 and OR 1.9; 95% CI 1.35–2.7, p < 0.001,
respectively) and age, BMI, hypertension, DM,ity according to constitution
el 2 Model 3
(95% CI) P value OR (95% CI) P value
7 (1.01–3.16) 0.045 1:1.79 (1.02–3.15) 0.044
2 (1.17–2.53) 0.006 1:1.74 (1.18–2.58) 0.006
5 (1.13–2.41) 0.01 1:1.51 (1.03–2.23) 0.037
(1.35–2.7) <0.001 1:1.88 (1.32–2.68) <0.001
and BMI. Model 3- adjusted for age, BMI, hypertension, DM,
angin; OR, odds ratio; CI, confidence interval.
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OR 1.51; 95% CI 1.03-2.23, p = 0.037 and OR 1.88; 95% CI
1.32–2.68, p < 0.001, respectively).Discussion
Several studies have suggested that the SC could be as-
sociated with some chronic diseases, and it has been rec-
ognized as an independent risk factor [19-23]. Recently,
a gene-level study also revealed that SC was associated
with AO [34]. In this cross-sectional study, we aimed to
determine whether the SC could be a risk factor for AO
among Koreans.
This study suggested that SC may be a significant and
independent risk factor of AO. Specifically, the TE type
was associated with increased AO prevalence compared
with the SE and SY types in males (OR 1.79; 95% CI
1.02–3.15, and OR 1.74; 95% CI 1.18–2.58, respectively)
and females (OR 1.51; 95% CI 1.03–2.23, and OR 1.88;
95% CI 1.32-2.68, respectively), even after adjusting for
age, BMI, hypertension, DM, hypertriglyceridemia, and
low HDL cholesterol. This result means that the TE type
could be more susceptible to AO than other types,
which is similar to the trend found for hypertension,
DM, and metabolic syndrome, which are associated with
SC [19-23].
The results revealed that the WC was different accor-
ding to SC type, and the TE type had the largest WC,
which was similar to other characteristics. The rates of
AO were different among SC types, and the rate of AO
in the TE type was higher than in other types in both
genders. However, because the comparatively larger WC
of the TE type may be caused by a relatively higher BMI,
age, and several chronic diseases [35], it is necessary to
explain the pure influence of SC itself. Accordingly, we
calculated ORs for AO with a logistic regression analysis
model after adjusting for the influence of potential vari-
ables. The multiple logistic regression analysis showed
that large differences in the OR between the TE type
and other types prior to adjusting for the potential vari-
ables (model 1) were still significant in models 2 and 3.
Furthermore, this trend was similar in both males and
females.
This trend supports the hypothesis that people classi-
fied as TE type might have a bigger belly and a higher
prevalence rate for AO compared with other types, even
if each type has similar physical characteristics. This fin-
ding might also be indirect evidence for SCM, which
suggests that body shape could develop differently from
one constitution to another.
In this study, we tried to enroll a representative Korean
population from nationwide centers. We also minimized
measurement error by following SOPs [30] and blood tes-
ting error by utilizing a qualified institution.The prevalence rates of AO in this study were rela-
tively high compared with a previous study conducted
by the Korean government [36]. For this reason, we as-
sumed that the average age in this study was relatively
higher.
Our study has several limitations. Previously, a large
Korean family study suggested a significant association
of chromosomes 8q11.22-23 and 11q22.1-3 with SC
[25], and another study found that SC was associated
with AO at the genetic level [34]. Family surveys and
gene-level studies could be a good method to demon-
strate whether SC is an inherent risk factor for AO.
However, because our study had a cross-sectional design,
we could not analyze the association between inherent
SC and AO. In addition, we did not control for environ-
mental factors, such as meals, lifestyle, and exercise
habits, which are acquired risk factors for AO.
We believe that further studies on not only a direct
comparison between constitutions considering acquired
environmental factors for AO but also on inherent fa-
mily SC are needed.
Conclusions
This study suggested that SC, especially the TE type,
might be significantly and independently associated with
AO. This finding reveals that SC should be considered a
risk factor in predicting AO.
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